Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
377,323,511
-
Share change
-
+18,048,107
-
Total reported value
-
$14,492,600,704
-
Put/Call ratio
-
39%
-
Price per share
-
$38.40
-
Number of holders
-
873
-
Value change
-
+$691,641,935
-
Number of buys
-
457
-
Number of sells
-
311
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q2 2025
As of 30 Jun 2025,
GSK plc - SPONSORED ADR (GSK) was held by
873 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
377,323,511 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, JTC Employer Solutions Trustee Ltd, Royal Bank of Canada, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, GOLDMAN SACHS GROUP INC, and Holocene Advisors, LP.
This page lists
875
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.